Label Image (Lbl500907413)
Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7413
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
This is a statistical analysis comparing the use of a drug (Rosuvastatin) versus a placebo in the study. The hazard ratio was found to be 0.56 with a 95% confidence interval between 0.46 and 0.69, indicating a significant difference between the two groups (P<0.001). The table shows the number of participants at risk over the years for each group.*
Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
This is a statistical data table comparing the efficacy of Roswa20mg versus Placebo20mg in a study with 8901 participants for different endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, and hospitalized unstable angina. The hazard ratio (HR) and p-values are provided for each endpoint, indicating the significant differences in outcomes between the two treatment groups. The table also includes event rates per 1000-patient years and specifies that cardiovascular death includes fatal MI, fatal stroke, sudden death, and other causes of cardiovascular death.*
Figure 3. (Rosuvastatin Fig3)
This text outlines the percent change from baseline in LDL-C (low-density lipoprotein cholesterol) levels for different statin medications at varying doses. The statins included are rosuvastatin, atorvastatin, simvastatin, and pravastatin. The doses evaluated for each medication are 10, 20, and 40 mg for most medications, with atorvastatin also including a dose of 80 mg. This information may be useful for comparing the efficacy of these statins in reducing LDL-C levels.*
Chemical Structure (Rosuvastatin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
